Scarica l'app Stockscreener
32.63
7.76%
2.35
Lenz Therapeutics Inc Borsa (LENZ) Ultime notizie
Wellington Management Group LLP Takes $585,000 Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 4.1%Time to Sell? - MarketBeat
BNP Paribas Financial Markets Has $63,000 Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
Presbyopia Therapeutics Market Size was highest in the US among the 7MM, was ~USD 8,039 million, and is expected to increase by 2034 | DelveInsight - Barchart
Presbyopia Therapeutics Market Size was highest in the US among - openPR
LENZ Therapeutics (NASDAQ:LENZ) Trading 5.8% HigherTime to Buy? - MarketBeat
Charles Schwab Investment Management Inc. Has $2.93 Million Stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
Charles Schwab Investment Management Inc. Has $2.93 Million Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Sotherly Hotels (NASDAQ:SOHOO) Shares Down 5% – Here’s What Happened - Defense World
XOMA (NASDAQ:XOMAP) Trading Down 0.6% – Should You Sell? - Defense World
Onfolio (NASDAQ:ONFO) Trading 1.1% Higher – Should You Buy? - Defense World
Sumco (OTCMKTS:SUMCF) Shares Up 2.4% – Still a Buy? - Defense World
Cizzle Biotechnology (LON:CIZ) Shares Down 5% – What’s Next? - Defense World
NeurAxis (NASDAQ:NRXS) Stock Price Down 5.3% – Here’s What Happened - Defense World
Glass House Brands (OTCMKTS:GLASF) Shares Up 1.3% – Here’s What Happened - Defense World
The Manufacturers Life Insurance Company Has $740,000 Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Century Lithium (CVE:LCE) Trading Down 1.7% – Here’s What Happened - Defense World
Shaftesbury Capital (LON:SHC) Trading Down 1.4% – Here’s What Happened - Defense World
Short Interest in DatChat, Inc. (NASDAQ:DATS) Drops By 56.0% - Defense World
Metal Sky Star Acquisition (NASDAQ:MSSAU) Trading 1.6% Higher – Should You Buy? - Defense World
Indaptus Therapeutics (NASDAQ:INDP) Shares Down 1% – Here’s Why - Defense World
AFC Energy (OTCMKTS:AFGYF) Shares Down 9.7% – What’s Next? - Defense World
Arizona Sonoran Copper (OTC:ASCUF) Trading 1% Higher – Time to Buy? - Defense World
Gusbourne (OTCMKTS:SLLFF) Trading Down 23.9% – Here’s Why - Defense World
The Manufacturers Life Insurance Company Sells 736 Shares of First Advantage Co. (NYSE:FA) - Defense World
The Manufacturers Life Insurance Company Reduces Stock Position in MFA Financial, Inc. (NYSE:MFA) - Defense World
The Manufacturers Life Insurance Company Invests $743,000 in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World
The Manufacturers Life Insurance Company Sells 3,598 Shares of iShares Semiconductor ETF (NASDAQ:SOXX) - Defense World
The Manufacturers Life Insurance Company Makes New Investment in Vanguard Utilities ETF (NYSEARCA:VPU) - Defense World
CG Oncology (NASDAQ:CGON) vs. LENZ Therapeutics (NASDAQ:LENZ) Head-To-Head Survey - Defense World
Parkman Healthcare Partners LLC Buys New Shares in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
We're Hopeful That LENZ Therapeutics (NASDAQ:LENZ) Will Use Its Cash Wisely - Yahoo Finance
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 4.7%Here's Why - MarketBeat
BBR Partners LLC Increases Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat
LENZ Therapeutics: Time For A Pause (NASDAQ:LENZ) - Seeking Alpha
AZEK’s (AZEK) Buy Rating Reiterated at Benchmark - Defense World
102,557 Shares in Kodiak Gas Services, Inc. (NYSE:KGS) Purchased by Victory Capital Management Inc. - Defense World
Top 10 startups in Ophthalmology in San Diego, United States in Nov, 2024 - Tracxn
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
LENZ Therapeutics, Inc. (LENZ) Is Up 3.37% in One Week: What You Should Know - MSN
Here's Why LENZ Therapeutics, Inc. (LENZ) Is a Great 'Buy the Bottom' Stock Now - MSN
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 6.3%Here's Why - MarketBeat
TANG CAPITAL MANAGEMENT LLC Expands Stake in LENZ Therapeutics I - GuruFocus.com
Presbyopia Treatment Market Set to Reach New Heights with New Therapies and Advancements by 2034 | DelveInsight - The Malaysian Reserve
LENZ Therapeutics (NASDAQ:LENZ) Hits New 1-Year HighWhat's Next? - MarketBeat
LENZ Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
LENZ Therapeutics to Present at 4 Major Healthcare Investor Conferences | LENZ Stock News - StockTitan
Leerink Partnrs Issues Optimistic Estimate for LENZ Earnings - MarketBeat
LENZ Therapeutics’ (LENZ) Buy Rating Reiterated at HC Wainwright - Defense World
Janux Therapeutics’ (JANX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
FY2024 EPS Estimate for LENZ Therapeutics Boosted by Analyst - MarketBeat
William Blair Has Bullish Outlook for LENZ FY2024 Earnings - MarketBeat
Patent Challenges Threaten Lenz Therapeutics’ Market Strategy and Financial Stability - TipRanks
LENZ stock touches 52-week high at $31.05 amid market optimism - Investing.com UK
Form 424B3 LENZ Therapeutics, Inc. - StreetInsider.com
LENZ Therapeutics Reports Third Quarter 2024 Financial Results - The Manila Times
Employ Inc. Announces Promotion of Stephanie Manzelli to Chief Human Resources Officer - The Manila Times
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):